S100A4 and cancer: CAFs exhibit enhanced expression of several markers, including α-smooth muscle actin (α-SMA), fibroblast activation protein (FAP), fibroblast-specific protein 1 (FSP1), platelet-derived growth factor receptor (PDGFR)-α/β, and poikilodulin (147), and the vast majority display pro-cancer effects (148).